Gmo Emerging Ntry Fund Current Valuation
| GMCDX Fund | USD 20.89 0.07 0.34% |
Valuation analysis of Gmo Emerging Ntry helps investors to measure Gmo Emerging's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Gmo Emerging's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Gmo Emerging Ntry retains a regular Real Value of $20.83 per share. The prevalent price of the fund is $20.89. We determine the value of Gmo Emerging Ntry from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we encourage acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will come together.
Since Gmo Emerging is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gmo Mutual Fund. However, Gmo Emerging's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.89 | Real 20.83 | Hype 20.89 | Naive 20.74 |
The intrinsic value of Gmo Emerging's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Gmo Emerging's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Gmo Emerging Ntry helps investors to forecast how Gmo mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gmo Emerging more accurately as focusing exclusively on Gmo Emerging's fundamentals will not take into account other important factors: Gmo Emerging Ntry Mutual Fund Current Valuation Analysis
Gmo Emerging's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Gmo Emerging Ntry has a Current Valuation of 0.0. This indicator is about the same for the GMO average (which is currently at 0.0) family and about the same as Emerging Markets Bond (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Gmo Fundamentals
| Total Asset | 3.31 B | |||
| Annual Yield | 0.23 % | |||
| Year To Date Return | 13.12 % | |||
| One Year Return | 20.51 % | |||
| Three Year Return | 3.60 % | |||
| Five Year Return | 3.92 % | |||
| Ten Year Return | 7.92 % | |||
| Net Asset | 3.87 B | |||
| Last Dividend Paid | 0.29 |
About Gmo Emerging Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gmo Emerging Ntry's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gmo Emerging using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gmo Emerging Ntry based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Gmo Mutual Fund
Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |